MUMBAI, India, May 30 -- Intellectual Property India has published a patent application (202517021792 A) filed by Genentech Inc., San Francisco, on March 11, for 'apparatus for subretinal administration of therapeutic agent via dual curved needle.'

Inventor(s) include Meyer Thomas E.; Wooley Chase; Stoner Kirsten; Creel Justin; Keane Michael; Camacho Sergio; Hedgeland Mark; Miser John; and Klingensmith Rory.

The application for the patent was published on May 30, under issue no. 22/2025.

According to the abstract released by the Intellectual Property India: "An apparatus includes a body a flexible cannula and a needle. The cannula is sized and configured to advance between a sclera and a choroid of a patients eye. The needle is slidably disposed in the cannula and includes a sharp distal tip. The needle translates relative to the cannula between a proximal position and a distal position. The distal tip is positioned inside the cannula when the needle is in the proximal position. The distal tip is positioned outside the cannula when the needle is in the distal position. The needle is resiliently biased to extend along at least one proximal curve through least one proximal curved needle portion. The needle is resiliently biased to extend along at least one distal curve through at least one distal curved needle portion. The at least one distal curve is different from the at least one proximal curve."

The patent application was internationally filed on Sept. 05, 2023, under International application No.PCT/IB2023/000521.

Disclaimer: Curated by HT Syndication.